CAS · 7414-83-7
Product Overview
Etidronate disodium is a high-purity nutrient-additives supplied for industrial and specialty chemical applications. Contact our team for specifications, packaging options and lead times.
Product Specifications
| Appearance | White or yellowish, hygroscopic powder |
|---|---|
| Content | 98.0%~101.0% |
| Solubility | Freely soluble in water, practically insoluble in acetone and in ethanol |
| IR | Complies with the CRS |
| Sodium Reaction | Positive |
| pH | 4.2~5.2 |
| Related substances Impurity A | ≤0.5% max |
| Impurity B | ≤0.5% max |
| Limit of phosphite | ≤1.0% max |
| Heavy Metals | ≤20 ppm max |
| Water Content | ≤5.0% max |
| Microbiological test Total aerobic microbial count | 10³ CFU/g max |
| Total molds and yeasts count | 10² CFU/g max |
| S. aureus | Absent in 1 g |
| P. aeruginosa | Absent in 1 g |
Applications
Etidronate disodium is primarily used as a therapeutic agent in the treatment and prevention of bone-related disorders. It is widely applied in the management of osteoporosis, Paget's disease, heterotopic ossification, and other conditions characterized by excessive bone resorption. The compound works by inhibiting the activity of osteoclasts, thereby reducing bone breakdown and maintaining bone density. In pharmaceutical formulations, it is often incorporated into tablets or oral solutions for patient administration. Beyond therapeutic uses, etidronate disodium is also utilized in biochemical and pharmacological research to study bone metabolism, mineralization processes, and the effects of bisphosphonates on cellular signaling pathways in bone tissue.
Benefits
Etidronate disodium offers several advantages due to its potent inhibition of bone resorption and its well-established safety profile. It effectively reduces bone turnover, enhances bone mineral density, and helps prevent fractures in patients with bone disorders. The disodium salt form improves water solubility, facilitating oral absorption and ease of formulation. Additionally, it provides consistent pharmacological activity and predictable dosing, making it suitable for both long-term therapy and acute interventions. The compound is also chemically stable under normal storage conditions, ensuring a reliable shelf life and consistent efficacy in pharmaceutical applications.
Conclusion
Etidronate disodium is a valuable bisphosphonate used for the treatment and prevention of bone disorders such as osteoporosis and Paget's disease. Its applications in maintaining bone density, inhibiting osteoclast activity, and supporting research on bone metabolism, combined with benefits such as solubility, stability, and clinical efficacy, make it an essential therapeutic agent in both healthcare and scientific research. The compound continues to play a significant role in improving bone health and advancing understanding of bone biology.
Previous
Next